25 MB of information … CONTENT OF THE CD-rom Learning appropriate use of antibiotics (PK/PD and guidelines): a CD-rom course for healthcare professionals.

Slides:



Advertisements
Similar presentations
Fig.3 Adverse effects of antiepileptic therapy in children: poly-therapy vs mono-therapy In-Service, Problem-Based Pharmacotherapy Teaching and Clinical.
Advertisements

1 Drug and Therapeutics Committee Session 10. Standard Treatment Guidelines.
Clinical Pharmacy Basma Y. Kentab MSc..
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Antimicrobial Stewardship St. Mary’s Hospital Infection Control Committee.
Infection Control Clinical Pharmacy and Patient Safety
Clinical Pharmacy Part 2
CHAMP Physician Education is Essential in Improving Antibiotic Use in Primary Care: review of behavioural interventions Alike van der Velden Marijke Kuyvenhoven.
| Slide 1 of 25 April 2007 Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Protea Hotel Victoria Junction, Waterfront.
PK/PD - ICC - Manila, June 5th, The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul.
Barriers to EBP Prepared by: Dr. Hoda Abed El-Azim.
Ten Years After: Where is ISAP?
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Antibiotic utilization in general medical units in a tertiary care institution Fernando GVMC, Ratnasekera IU, Perera MSD, Wanigatunge CA.
Monitoring and Evaluation Systems for NARS organizations in Papua New Guinea Day 4. Session 10. Evaluation.
MACROLIDES: pharmacokinetics and pharmacodynamics
Antimicrobial Stewardship
Isabelle K. Delattre, Françoise Van Bambeke and Paul M. Tulkens
Setting-up a model of intracellular infection by Pseudomonas aeruginosa for the pharmacodynamic evaluation of antibiotic activity. J. Buyck1, O. Jolois2,
Activities of Daptomycin (DAP), Vancomycin (VAN) and Linezolid (LDZ) alone or in combination with Fusidic acid (FUS) in an in vitro dynamic model of.
Comparison of the intracellular and extracellular activities of approved and novel antistaphylococcal antibiotics using a pharmacodynamic model exploring.
In vitro pharmacodynamic models for the study of antibiotic activity against bacterial biofilms Françoise Van Bambeke, PharmD, PhD Pharmacologie cellulaire.
Introduction to the workshop and overview of our work together.
Representative of ISC to EUCAST
Temocillin pharmacokinetics in healthy volunteers
P 166 Introduction Description of the analyzed population
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul M. Tulkens Cellular and Molecular.
ANTIBIOTIC MANAGEMENT TEAMS IN BELGIAN HOSPITALS :
FUS, VAN and LZD injected twice (T0 and T12); DAP injected once (T0).
This poster will be made available for download after the meeting at :
Epithelial lining fluid penetration of temocillin administered by continuous infusion in critically ill patients with nosocomial pneumonia. Visée C.1a,
Influence of antibiotic treatments on gene expression of RND efflux pumps in successive isolates of Pseudomonas aeruginosa collected from patients with.
Introduction Results Aim Methods References Conclusion
Aminoglycoside nephrotoxicity: from molecular pharmacology and pathology to some applications Paul M. Tulkens, MD, PhD Unité de Pharmacologie Cellulaire.
Inhibitors of type three secretion system [TTSS] protect against Pseudomonas aeruginosa cellular toxicity by inhibiting the transcription of TTSS Mailing.
Mapping French population [1]
Making Technical Cooperation work for capacity building
18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) Barcelona, Spain, April 2008 Oral presentation O249 – Sunday April.
Are Vitek2 system and E-test relevant and reliable for determining susceptibility to temocillin? Visée C.1, Frippiat F1, Descy J.2, Meex C.2, Melin P.2,
Extracellular activity Intracellular activity
Abstract Results Methods Background Conclusions References
Apoptosis induced by aminoglycosides (AGs) in cultured cells : comparison between gentamicin (GEN) and amikacin (AMK) using incubated and electroporated.
The machine and its calibration
Abstract Results Aim of the study Methods Background Conclusions
Antibiotic activity of new penams (6-APA) and cephems (7-ACA)
Difference log CFU from time 0
Oral session: PK/PD-based optimized broad-spectrum beta-lactam therapy (Sunday 10 April, 11:30) Achieving pharmacokinetic/pharmacodynamic (PK/PD) targets.
INTRODUCTION METHODS CONCLUSIONS REFERENCES
Electron microscopy: intracellular infection of THP-1 by S. aureus
Susceptibility of Pseudomonas aeruginosa (P. a
Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) Paul M. Tulkens.
Financial Accounting | Basic Concepts and Principles.
F. Van Bambeke & P.M. Tulkens
Impact of a public education program on promoting rational use of medicines:
Doripenem vs Meropenem: a summary of International and Belgian published data Françoise Van Bambeke, Unité de Pharmacologie cellulaire et moléculaire Louvain.
Hospital Antibiotic Stewardship Programs
Evaluating Provision for Students with Additional and Special Educational Needs in Post-Primary Schools Briefing for the Education Partners 4th September.
M.P. Mingeot-Leclercq, P.M. Tulkens, F. Van Bambeke
Intracellular models of infection to evaluate antibiotic activity
A.E. Muller, U. Theuretzbacher, J.W. Mouton 
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Pharmacy practice experience I
Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription  B. Maraha, M. Bonten, H. Fiolet,
Setting-up of a 24 h model to evaluate the activity of antibiotics against intracellular forms of S. aureus infection C. Seral, M. Barcia-Macay, F. Van.
Evaluating Provision for Students with Additional and Special Educational Needs in Post-Primary Schools Briefing for the Education Partners 4th September.
Impact of antibiotic restrictions: the patient's perspective
Making Technical Cooperation work for capacity building
Université catholique de Louvain, Brussels, Belgium
Presentation transcript:

25 MB of information … CONTENT OF THE CD-rom Learning appropriate use of antibiotics (PK/PD and guidelines): a CD-rom course for healthcare professionals and students E. Ampe, Y. Glupczynski, P.M. Tulkens, and F. Van Bambeke Unité de Pharmacologie cellulaire et moléculaire, Université catholique de Louvain - Brussels - Belgium Laboratoire de microbiologie, Cliniques universitaires UCL, Mont-Godinne Mailing address: P.M. Tulkens UCL av. Mounier Brussels - Belgium ABSTRACT Objectives: In a context of growing resistance and limited supply of new molecules, a rational use of antibiotics should be a high priority. Our objective is to train healthcare professionals and students in PK/PD and in a correct implementation of guidelines, since this could help to improve antibiotic use in both short and mid-terms. Methods: We developed a PK/PD – guidelines course on CD-rom, targeted to both physicians and pharmacists but also usable by students. The course was prepared by a team of 2 pharmacists, 1 clinical microbiologist, and 1 pharmacologist. Sources of information were (i) textbooks, review papers and primary papers by internationally recognized experts (ii) materials presented at training workshops of the International Society for Antiinfective Pharmacology (ISAP; during the last 3 years, (iii) national and, if not available, international guidelines for the management of respiratory tracrtor urinary tract infections. Results: The course is organized as a series of Power Point presentations covering in a progressive fashion the followings topics : (1) bases in microbiology (in vitro properties of antibiotics); (2) pharmacokinetics (definition of the main parameters); (3) pharmacodynamics, with (A) the concepts, (B) the methods and pertinent models, and (C) the data, including the parameters to take into account to optimize the dosage of the main antibiotic classes; (4) resistance, including (A) the main mechanisms and (B) the use of pharmacodynamics to avoid the selection of resistance; (5) the appropriate use (including appropriate dosages) of antibiotics in (A) respiratory tract and (B) urinary tract infections. Conclusions:This course promotes continuous education in the pharmacology and pharmacotherapy of antibiotics, in a format easily usable for courses and seminars to both students and professionals. OBJECTIVES  to develop an educational programme in which pharmacists and infectious disease specialists train healthcare professionals and students in PK/PD and in a correct implementation of guidelines.  to distribute to people following this course a CD-rom as a support that can be consulted at any time. INTRODUCTION Optimizing the use of current antibiotics based on pharmacokinetics and pharmacodynamics and rational application of guidelines can contribute to the limitation of resistance development. In this respect, education of students and healthcare professionals appears as a priority and can be facilitated by making available to them easy-to-consult informative supports. WHAT WE HOPE AND WHAT WE WILL DO:  the CD-rom should be a continuous information source that  could be used for teaching pharmacology and pharmacotherapy of antibiotics to students and healthcare professionals.  may be easily consulted by healthcare professionals at any moment.  We will regularly update it and plan to evaluate its impact on education of students and on the quality of antibiotic prescribing of junior physicians SECTION 2. DEFINITION OF PK PARAMETERS SECTION 3. DEFINITION OF PD PARAMETERS GUIDELINES RESPIRATORY TRACT INFECTIONS Principles Application of PK:PD concepts SECTION 4. GUIDELINES ACKNOWLEDGMENTS: We thank W. Peetermans (KUL- UZ Gasthuisberg) for useful comments and Bayer Belgium for financial support SECTION 1. DEFINITION OF MICROBIOLOGICALPARAMETERS P878 GUIDELINES URINARY TRACT INFECTIONS Principles Applications of PK/PD concepts